Regulation - North America, siltuximab

Filter

Current filters:

North Americasiltuximab

Popular Filters

Janssen files for simultaneous US and EU approval for Castleman disease drug

04-09-2013

Janssen Research & Development, a subsidiary of US health care giant Johnson & Johnson (NYSE: JNJ), yesterday…

EuropeJanssenJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRare diseasesRegulationsiltuximab

Company Spotlight

ImmunoGen

ImmunoGen

Back to top